Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.2
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 23001012
De Clercq S, et al. (2013) Nanobody-induced perturbation of LFA-1/L-plastin phosphorylation impairs MTOC docking, immune synapse formation and T cell activation. Cell Mol Life Sci 70, 909-22 23001012
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S745-p - ITGB2 (human)
Modsite: FEkEKLksQWNNDNP SwissProt Entrez-Gene
Orthologous residues
ITGB2 (human): S745‑p, ITGB2 (mouse): S747‑p, ITGB2 (rat): S744‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Disease tissue studied:  leukemia, T cell leukemia
Relevant cell lines - cell types - tissues:  Jurkat (T lymphocyte)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPL increase nanobodies that interfere with LPL cause decrease
antibody increase

S5-p - L-plastin (human)
Modsite: ___MARGsVsDEEMM SwissProt Entrez-Gene
Orthologous residues
L‑plastin (human): S5‑p, L‑plastin (mouse): S5‑p, L‑plastin (rat): S5‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Disease tissue studied:  leukemia, T cell leukemia, lymphoma, Burkitt's lymphoma
Relevant cell lines - cell types - tissues:  Jurkat (T lymphocyte), Raji (B lymphocyte)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPL increase nanobodies that interfere with LPL cause decrease
antibody increase
Downstream Regulation
Effect of modification (function):  intracellular localization, molecular association, regulation
Effect of modification (process):  cytoskeletal reorganization
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
ITGB2 (human) Induces co-immunoprecipitation
Comments:  immune synapse formation